Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (2)

2017

  1. Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

    European Journal of Cancer, Vol. 75, pp. 73-82

2015

  1. Methylation of CpG sites in BCL2 major breakpoint region and the increase of BCL2/JH translocation with aging

    Age, Vol. 37, Núm. 5